Overview
Jingjin Hu practices practicing medicine in Hangzhou, China.
Their clinical expertise encompasses Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, and H1N1 Influenza.
They are actively involved in clinical research, co-authoring 15 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jingjin Hu
Is Jingjin Hu a top-rated expert for Doxorubicin-Induced Cardiomyopathy?
MediFind is an objective health platform that identifies experts based on real-world data. Jingjin Hu is classified as an Experienced expert for Doxorubicin-Induced Cardiomyopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jingjin Hu participate in research or clinical trials?
Yes. Jingjin Hu has published 15 articles and abstracts on conditions like Doxorubicin-Induced Cardiomyopathy. You can view a list of Jingjin Hu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cardiomyopathy Due to Anthracyclines
- Doxorubicin-Induced Cardiomyopathy
- H1N1 InfluenzaHu isExperienced. Learn about H1N1 Influenza.